Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Apyx Medical (APYX) Net Margin (2016 - 2026)

Apyx Medical filings provide 15 years of Net Margin readings, the most recent being 6.78% for Q4 2025.

  • On a quarterly basis, Net Margin rose 2576.0% to 6.78% in Q4 2025 year-over-year; TTM through Dec 2025 was 21.22%, a 2756.0% increase, with the full-year FY2025 number at 21.22%, up 2756.0% from a year prior.
  • Net Margin hit 6.78% in Q4 2025 for Apyx Medical, up from 15.41% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 6.78% in Q4 2025 to a low of 73.96% in Q1 2024.
  • Median Net Margin over the past 5 years was 39.8% (2023), compared with a mean of 39.73%.
  • Biggest five-year swings in Net Margin: skyrocketed 7308bps in 2021 and later crashed -4645bps in 2024.
  • Apyx Medical's Net Margin stood at 11.95% in 2021, then plummeted by -303bps to 48.09% in 2022, then plummeted by -36bps to 65.52% in 2023, then skyrocketed by 50bps to 32.54% in 2024, then skyrocketed by 79bps to 6.78% in 2025.
  • The last three reported values for Net Margin were 6.78% (Q4 2025), 15.41% (Q3 2025), and 33.22% (Q2 2025) per Business Quant data.